New England Psychologist - nepsy.com Banner Ad
An Independent Voice for the State's Psychologist
Psy Jobs CE Listings Archives Contact
HomeColumnsBook ReviewsHospital DirectoryAdvertisingAbout Us

Debate on Ritalin use continues
(October 2003 Issue)

By Ami Albernaz

Given rising concerns over the number of children on Ritalin and other psychotropic drugs, state legislatures throughout the country have been debating measures that would curb recommendations of such drugs in schools.

While controversy has swirled around student use of Ritalin (methylphenidate) over the past decade, the issue has received more attention in the past few years. Stimulants counteracting Attention Deficit Disorder are now directly marketed to parents. Such drugs received an additional boost when the American Academy of Pediatrics endorsed their use, provided clear goals and monitoring. Such moves added to concerns that drugs are being suggested too quickly.

"There's concern about the unusually high number of children on psychotropic medications," said Andrew Gersten, Ph.D., a psychologist on the New Hampshire Psychological Association's legislative committee and a school consultant. New Hampshire is one of two New England states where bills concerning psychotropic drugs in schools were recently presented. Of five such laws proposed in the Granite State, three were killed and two are still being studied.

Perhaps nowhere in the country is the debate so relevant as in New England. The region leads the country in consumption of Ritalin and its generics: New Hampshire rates first, followed by Vermont, Massachusetts, Rhode Island and Maine.

That New England states dispense more Ritalin per capita than anywhere else is a cause for alarm among some practitioners, including J. David Egner, M.S., a child psychologist and former special education director in Rutland, Vt. Speaking of his own state, he says, "Vermont is rural; there's no inner-city ghetto problem. There are incredibly small classrooms. But options of alternatives (to Ritalin) aren't discussed."

A bill that was defeated in the Vermont legislature last year would have required schools to tell parents that their children need not use Ritalin even when it is advised by an outside doctor or therapist.

Egner supported the bill, and still believes that a harder line needs to be taken on Ritalin and similar drugs. He says he has known parents who have been pressured by school officials to start their children on Ritalin or a similar drug. Meanwhile, he adds, Ritalin has become the most prevalent street drug in Rutland.

Connecticut is the one New England state to have a so-called anti-Ritalin law. In 2001, the legislature ruled that schools could recommend therapists, and not drugs, to students. Supporters say that such a law clarifies the boundaries involved in suggesting medications.

"The purpose of the bill is to ensure that the person who is prescribing medication is the best qualified," says Michael Schwarzchild, Ph.D., director of the Center for Child and Adolescent Behavior in Brookfield, Conn. While the Connecticut bill met little opposition, it was regarded by some, including the state's Board of Education, as redundant, because an outside professional would be needed to prescribe medication in any case.

Nationwide, Texas, Virginia and Minnesota are among states to have also passed "anti-Ritalin" laws.

That such laws have not been passed in other New England states is perhaps a reflection of other preoccupations, such as severe budget crises or the belief that Ritalin is, for the most part, safe. In New Hampshire, the measures struck down this year included the creation of a committee to study psychotropic use in schools; another would have prohibited any government agency employee from recommending psychotropic drugs to children.

The measures still under study, meanwhile, include a parental bill of rights concerning school disciplinary actions and psychotropic drugs in schools and one that would establish legal guidelines for when parents refuse to put their children on psychotropic medications.

Balancing the attempts to curb psychotropic drugs in schools is a defense of the drugs, which for many children, seem to have worked well.

Kirsten Singleton, executive director of the New Hampshire Psychological Association, says that had the Ritalin debate gone further in New Hampshire, the association would have sought to "educate the legislature, and give them a balanced view."

Meanwhile, even in states where no laws curbing recommendations of psychotropic drugs have been passed, some school systems have advised personnel to avoid suggesting medication directly and to instead advise seeing an outside professional. This course of action is sensible, Gersten says.

"It's appropriate for school personnel to suggest a physician to see if medications would be helpful," he says. "It's no different from recommending another specialist such as a neurologist."

The battle over Ritalin and similar drugs in schools will likely continue. A recent demonstration in Concord, N.H. by a Massachusetts-based civil rights group called for the outright ban of such drugs. While a ban appears unlikely, firmer guidelines of how psychotropic drugs will be recommended and handled in schools - or at least debates on what the guidelines should be - are anticipated.